SHPG has historically reported excellent results and steady growth over many years with only rare exceptions. In view of yet another great earnings report and strong guidance today, I decided to add a bit more at 195 . I plan to slowly rebuild a long position I recently exited at 260 after holding the stock for close to two decades. GLTA.
@@@@@Co increases guidance: Now expect to deliver Non GAAP earnings per ADS growth in the high thirty percent range in 2014 (previous guidance: low-to-mid thirty percent growth). Now expect product sales growth for the full year 2014 in the low twenty percent range (previous guidance: high teens growth).
Here's why: Allergan has been fighting off the vampire Valient's take over bid. Valient, if you didn't know, doesn't make anything. They just acquire companies, suck their pipeline, and move on to the next victim. John Paulsen who owns Allergan and Shire got caught up in this mess. He is down over a billion dollars on Shire since Abbvie fell through. The acquisition of Shire by Allergan would grow the balance sheet and deplete cash, significantly degrading Valient's ability to execute a hostile takeover. Since the Valient deal is being brokered by Bill Ackman, I further believe other activist shareholders like Icahn and Dan Loeb (both of whom have scored big taking the other side of Ackman's trades) would emerge to take the other side of Ackman's bet. Jim Chanos is already short Valient, because, again, they don't make anything (what Valient does is accounting manipulation on businesses they acquire....Ackman recently said that GAAP rules don't aplly to companies like Valient). More and more, I am convinced of this potential outcome and will be adding again on any pullbacks. I have nailed this trade thus far. Good luck.
I added more yesterday almost doubled my stake and once again wish I had added more. I wonder how Abbvie is feeling now. Quarterly growth of 33% on rev and EBITDA growth of 46% smash forecasts and guarantee the will hit the current annual forecasts which will likely be raised. As valuations increase future buyout premiums increase as well. Thank you panickers who dumped their shares!!! Your loss is my gain.
Haha... Not me... I am trying to rebuild a long position after cashing out at 260. So far only got a first small order filled at 165 and I want more!
No idea whether it will go up or down.... just pointing out that earnings will be out so there could be some significant movement up or down.
i picked up a small limit order in the last minute. I agree, we could get some dips to buy on. Some lucky person got $172 in extended hours yesterday. I am going to do some fishing tomorrow and see if I can pick up something with a limit order. It can drop $13 and I'm still in the money.
I wish I had bought more when this dropped and I am hoping for another dip. Now that we know the fair market value of this company, buying this was a no brainer. Now they are almost two billion dollars richer and STILL have buyout potential. This is going to be an interesting story in the months ahead.
I'm new to this stock and just bought some calls going into earnings. I'm just curious how this stock has reacted to earnings in the recent past. For example, if they were to beat significantly as they have frequently, will it be a major catalyst? Lately, it seems like most of the movement has been based on the AbbieVie, and now Allergan merger, but I'm wondering if earnings will still be a significant event.
The BoD already recomended abbv sh's to vote against. As an 18 year shire owner I am fine because we will continue high growth for another ten years. This wouldn't have been possible as a combined company.
Besides, I won't have to write a big check to the IRS so our government can waste it!